tiprankstipranks
Trending News
More News >
Instadose Pharma (INSD)
OTHER OTC:INSD
US Market

Instadose Pharma (INSD) Financial Statements

Compare
18 Followers

Instadose Pharma Financial Overview

Instadose Pharma's market cap is currently $532.00. The company's EPS TTM is $; its P/E ratio is ―; Instadose Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00-
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00-
Operating Income$ 0.00--$ -23.27K$ -23.54K
EBITDA$ 0.00$ 0.00$ 0.00$ -23.27K-
Net Income$ 0.00----
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 0.00$ 3.00K---
Total Debt$ 0.00$ 0.00$ 0.00$ 55.66K$ 32.73K
Net Debt$ 0.00$ 0.00-$ 55.58K$ 32.60K
Total Liabilities$ 0.00$ 206.80K$ 206.80K$ 107.02K$ 44.52K
Stockholders' Equity$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cash Flow
Free Cash Flow$ 0.00----
Operating Cash Flow$ 0.00----
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00---
Currency in USD

Instadose Pharma Earnings and Revenue History

Instadose Pharma Debt to Assets

Instadose Pharma Cash Flow

Instadose Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis